ARCHIVES

President Signs Supplemental Funding For NIH And FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 27 | July 11, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Groups Lobby Congress For $5.8 Billion Budget For NCI, Increases For Other Programs

June 18, 2010

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

February 25, 2011

ASCO, ONS Issue Standards For Safe Chemotherapy Administration

October 2, 2009

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013